AI Buyer Insights:

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

List of Komodo Health Aperture Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
AstraZeneca US Life Sciences 17535 $17.7B United States Komodo Health Komodo Health Aperture Analytics and BI 2017 n/a
In 2017, AstraZeneca US implemented Komodo Health Aperture as an Analytics and BI application. The deployment targeted regional teams and was supported by AstraZeneca US technology staff who provided training on Komodo Health Aperture, Veeva CRM, and Microsoft Suite to operational users. Komodo Health Aperture was positioned to deliver analytics and BI capabilities for regional operational workflows, with configuration and user enablement managed by the internal tech team. Training activities documented platform navigation, data access patterns, and coordinated cross platform usage with Veeva CRM and Microsoft Suite, and the rollout emphasized governance for user onboarding and ongoing support.
Bristol Myers Squibb Life Sciences 34100 $48.3B United States Komodo Health Komodo Health Aperture Analytics and BI 2015 n/a
In 2015, Bristol Myers Squibb conducted a big data analytics pilot using Komodo Health Aperture 2.0. The pilot deployed Komodo Health Aperture as an Analytics and BI capability to identify new health care provider engagement opportunities for Field Medical and the home office supporting the US Immuno Oncology Franchise Medical team. Configuration emphasized Aperture 2.0 data ingestion and analytics capabilities to surface HCP engagement opportunities, with functional workflows focused on HCP identification, cohort oriented analysis, and opportunity detection to inform medical engagement planning. The pilot implementation prioritized query driven analytics and user facing dashboards to present actionable signals to franchise medical users. Access management was implemented via SAML 2.0 to control authentication across field and home office users. Operational coverage explicitly included Field Medical and the home office for the US Immuno Oncology Franchise Medical team, and governance during the pilot centered on data access controls and role aligned permissions to align medical affairs workflows to the Aperture driven opportunity identification process.
Cholangiocarcinoma Foundation Life Sciences 20 $3M United States Komodo Health Komodo Health Aperture Analytics and BI 2019 n/a
In 2019, Cholangiocarcinoma Foundation implemented Komodo Health Aperture to centralize disease burden and research analytics. The deployment positioned Komodo Health Aperture as the foundation's Analytics and BI platform for research and program planning, providing a single environment for population level insight and hypothesis generation. Komodo Health Aperture was configured to deliver cohort discovery, population level disease burden analysis, epidemiologic analytics, and interactive dashboards tailored to a small research organization. The implementation emphasized data modeling, curated visualizations, and repeatable analytic workflows to support research questions and program prioritization within the foundation. The platform was operationalized across the foundation's research, program, and advocacy functions with role based access controls and curated analytic workspaces to manage sensitive datasets. The engagement illustrates Komodo Health Aperture being used to help tackle the burden of disease for the Cholangiocarcinoma Foundation and to serve as an Analytics and BI resource for ongoing research activities.
Non Profit 23 $3M United States Komodo Health Komodo Health Aperture Analytics and BI 2019 n/a
Life Sciences 69310 $42.2B United Kingdom Komodo Health Komodo Health Aperture Analytics and BI 2019 n/a
Showing 1 to 5 of 5 entries

Buyer Intent: Companies Evaluating Komodo Health Aperture

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Komodo Health Aperture. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating Komodo Health Aperture for Analytics and BI include:

  1. 5R Design, a United States based Professional Services organization with 10 Employees
  2. United BioSource, a United States based Life Sciences company with 1500 Employees

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Komodo Health Aperture Coverage

Komodo Health Aperture is a Analytics and BI solution from Komodo Health.

Companies worldwide use Komodo Health Aperture, from small firms to large enterprises across 21+ industries.

Organizations such as Bristol Myers Squibb, GSK, AstraZeneca US, Cholangiocarcinoma Foundation and Fight Colorectal Cancer are recorded users of Komodo Health Aperture for Analytics and BI.

Companies using Komodo Health Aperture are most concentrated in Life Sciences and Non Profit, with adoption spanning over 21 industries.

Companies using Komodo Health Aperture are most concentrated in United States and United Kingdom, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Komodo Health Aperture across Americas, EMEA, and APAC.

Companies using Komodo Health Aperture range from small businesses with 0-100 employees - 40%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 60%.

Customers of Komodo Health Aperture include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Komodo Health Aperture customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Analytics and BI.